Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Izabela Rybicka

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Applied and Environmental Microbiology|April 16, 2025
The human phageome: niche-specific distribution of bacteriophages and their clinical implicationsIzabela Rybicka, Zuzanna Kaźmierczak
Cell Host & Microbe|July 8, 2026
Breaking down barriers to improve phage therapy deliveryTiffany Luong, Izabela Rybicka, Patrick Blankenberg, et al.
Current Issues in Molecular Biology|February 27, 2026
Physicochemical and Proteolytic Barriers Limiting Activity of Cpl-1 and Pal Endolysins in Human CirculationMarek Adam Harhala, Katarzyna Gembara, Izabela Rybicka, et al.
Microbiology Spectrum|September 19, 2023
Evolution of the T4 phage virion is driven by selection pressure from non-bacterial factorsJoanna Majewska, Paulina Miernikiewicz, Aleksander Szymczak, et al.
Frontiers in Immunology|October 2, 2023
Immunogenic epitope scanning in bacteriolytic enzymes Pal and Cpl-1 and engineering Pal to escape antibody responsesMarek Adam Harhala, Katarzyna Gembara, Izabela Rybicka, et al.
Viruses|January 23, 2024
Experimental Identification of Cross-Reacting IgG Hotspots to Predict Existing Immunity Evasion of SARS-CoV-2 Variants by a New Biotechnological Application of Phage DisplayMarek Adam Harhala, Katarzyna Gembara, Krzysztof Baniecki, et al.
Cells|August 11, 2023
New Phage-Derived Antibacterial Enzyme PolaR Targeting <i>Rothia</i> sppPaulina Miernikiewicz, Jakub Barylski, Aleksandra Wilczak, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Applied and Environmental Microbiology|April 16, 2025
The human phageome: niche-specific distribution of bacteriophages and their clinical implicationsIzabela Rybicka, Zuzanna Kaźmierczak
Cell Host & Microbe|July 8, 2026
Breaking down barriers to improve phage therapy deliveryTiffany Luong, Izabela Rybicka, Patrick Blankenberg, et al.
Current Issues in Molecular Biology|February 27, 2026
Physicochemical and Proteolytic Barriers Limiting Activity of Cpl-1 and Pal Endolysins in Human CirculationMarek Adam Harhala, Katarzyna Gembara, Izabela Rybicka, et al.
Microbiology Spectrum|September 19, 2023
Evolution of the T4 phage virion is driven by selection pressure from non-bacterial factorsJoanna Majewska, Paulina Miernikiewicz, Aleksander Szymczak, et al.
Frontiers in Immunology|October 2, 2023
Immunogenic epitope scanning in bacteriolytic enzymes Pal and Cpl-1 and engineering Pal to escape antibody responsesMarek Adam Harhala, Katarzyna Gembara, Izabela Rybicka, et al.
Viruses|January 23, 2024
Experimental Identification of Cross-Reacting IgG Hotspots to Predict Existing Immunity Evasion of SARS-CoV-2 Variants by a New Biotechnological Application of Phage DisplayMarek Adam Harhala, Katarzyna Gembara, Krzysztof Baniecki, et al.
Cells|August 11, 2023
New Phage-Derived Antibacterial Enzyme PolaR Targeting <i>Rothia</i> sppPaulina Miernikiewicz, Jakub Barylski, Aleksandra Wilczak, et al.
Pageof 1